Variant report
Variant | esv9745 |
---|---|
Chromosome Location | chr6:131809780-131816116 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17656494 | chr6:131809785-131809786 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs77037406 | chr6:131809821-131809822 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs386705889 | chr6:131809824-131809825 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs116231607 | chr6:131809825-131809826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533876342 | chr6:131809865-131809866 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565712439 | chr6:131809892-131809893 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34528680 | chr6:131809917-131809918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs2807278 | chr6:131809920-131809921 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
9 | rs186737507 | chr6:131809928-131809929 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544407846 | chr6:131809949-131809950 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2608968 | chr6:131809958-131809959 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs2781657 | chr6:131809959-131809960 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35138731 | chr6:131809986-131809987 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575721584 | chr6:131809987-131809988 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541456766 | chr6:131810040-131810041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560230184 | chr6:131810048-131810049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189581906 | chr6:131810050-131810051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79039113 | chr6:131810106-131810107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs77131834 | chr6:131810107-131810108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2446221 | chr6:131810223-131810224 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs2446222 | chr6:131810238-131810239 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs532562835 | chr6:131810403-131810404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551164853 | chr6:131810404-131810405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569210006 | chr6:131810421-131810422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536803697 | chr6:131810427-131810428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141647693 | chr6:131810450-131810451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77819585 | chr6:131810490-131810491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2446223 | chr6:131810634-131810635 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs558394259 | chr6:131810691-131810692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570419771 | chr6:131810711-131810712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537593628 | chr6:131810741-131810742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs371882469 | chr6:131810770-131810771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs59865379 | chr6:131810792-131810793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs2807279 | chr6:131810794-131810795 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs181115726 | chr6:131810795-131810796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574439053 | chr6:131810811-131810812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142757424 | chr6:131810860-131810861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2608969 | chr6:131810924-131810925 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs572043229 | chr6:131810928-131810929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531096502 | chr6:131810948-131810949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186151252 | chr6:131810957-131810958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35682526 | chr6:131810983-131810984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375858465 | chr6:131810990-131810991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs386705890 | chr6:131811030-131811031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1572211 | chr6:131811031-131811032 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs374626650 | chr6:131811058-131811059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150506825 | chr6:131811089-131811090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs1572212 | chr6:131811111-131811112 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs148636681 | chr6:131811120-131811121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546949257 | chr6:131811127-131811128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:131799400-131811200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:131809400-131810000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr6:131810000-131811600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:131811200-131812000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr6:131811200-131812000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr6:131811400-131813400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr6:131811600-131812200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr6:131811600-131813600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr6:131812000-131812200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr6:131812200-131812800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:131812800-131813000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:131813000-131813400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr6:131813400-131815600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr6:131815600-131818600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |